Lea Surrey

24PUBLICATIONS

167CO-AUTHORS

Molecular targetsLiquid biopsiesImmunogenetics (incl. genetic immunology)Neurology and neuromuscular diseasesSolid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Jun 13, 2026

The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

|Apr 16, 2026

Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

|Apr 11, 2026

A High-Sensitivity Circulating Nucleic Acid Sequencing Assay for Assessing Treatment Response to Alectinib in a Pediatric Patient With ALK-Rearranged Non-Small Cell Lung Cancer.

Alberto D Guerra, Nicholas F Evageliou, Vandana Batra

|Jan 14, 2026

Molecular Characterization of a Complex <i>PDGFRB</i> Structural Variation in Infantile Myofibroma With Complete Response to Imatinib.

Wynn E Bastianelli, Jinhua Wu, Mian Umair Ahsan

|Sep 24, 2025

Reprogramming neuroblastoma by diet-enhanced polyamine depletion.

Sarah Cherkaoui, Christina S Turn, Yuan Yuan

|Aug 06, 2025

The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity.

John Maris, Isabel Soria-Bretones, Matias Casás-Selves

Pageof 4

Frequent Collaborators

Theodore W Laetsch

Oscar Lopez-Nunez

John Maris

David Groff

Alvin Farrel

Yael P Mossé

Michael D Hogarty

Rebecca S Kaufman

Andrew J Bauer

Minjie Luo

Frequent Collaborators

Theodore W Laetsch

Oscar Lopez-Nunez

John Maris

David Groff